DXB 1.30% 7.6¢ dimerix limited

Ann: Dual Phase 2 trials launched for CKD, page-3

  1. 269 Posts.
    lightbulb Created with Sketch. 110
    I disagree. I get we are doing two simultaneous phase two trials now which is great but we were informed less than six months ago that recruitment for FSGS was going to commence in Q1 CY2018 with exploratory 2b read out in CY2018. Recruitment is now ‘expected’ to commence in Q3 CY2018 with preliminary data not ‘expected’ until Q3 CY2019. Now wonder Cathy has been shown the door…value is some way off yet and IMO a new CEO cannot come soon enough. Hopefully we get someone at the helm who can adhere to timelines and do more than one thing a time as the CR seems to have halted any actual progress beyond planning. Very disappointing. Looks like I will be wait another 12+ months for my 10 bags from this one.
watchlist Created with Sketch. Add DXB (ASX) to my watchlist
(20min delay)
Mkt cap ! $12.06M
Open High Low Value Volume
7.7¢ 7.7¢ 7.6¢ $35.82K 470.7K

Buyers (Bids)

No. Vol. Price($)
3 220000 7.5¢

Sellers (Offers)

Price($) Vol. No.
7.8¢ 6379 1
View Market Depth
Last update - 16.10pm 21/05/2019 (20 minute delay) ?
-0.001 ( 1.30 %)
Open High Low Volume
7.6¢ 7.7¢ 7.6¢ 51935
Last updated 14.50pm 21/05/2019 (live) ?
DXB (ASX) Chart
GET SUPPORT arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.